Adults
TrialNet Pathway to Prevention T1D
Screening and Monitoring
Joslin Diabetes Center, Boston, MA
Yale University, New Haven, CT
Naomi Berrie Diabetes Center, New York, NY
Multiple Other Sites
STOP T1D
Low Dose Antithymocyte Globulin (ATG) to Delay or Prevent Progression to Stage 3 T1D
Naomi Berrie Diabetes Center, New York, NY
Yale University, New Haven, CT
STOP-T1D Trial Website
PREDICT Study
Phenotyping Relatives of persons with Diabetes with CGM and Tests of beta cell function and health
Yale University, New Haven, CT
Recruiting
Immune Function Study
PROMISE Study
PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life
Icahn School of Medicine at Mount Sinai, New York, NY
Joslin Diabetes Center, Boston, MA
- The safety and scientific validity of a research study is the responsibility of the study investigators and the study sponsor.
- It is important to evaluate the risks and potential benefits of clinical studies and to talk to your health care provider(s) before participating in a study.